The companies haven’t published the trial data, but they said the experimental treatment extended the time before cancer ...

Healthwatch Rotherham has highlighted residents' concerns that a new AI GP receptionist has difficulty understanding ...

Regeneron’s Pasatru is the second fibrodysplasia ossificans progressiva drug approved in the U.S., following the 2023 ...

DUBLIN--ICON releases 2025 ICON Cares Report, highlighting progress in patient impact, innovation and sustainability ...

Mississippi's medical, nursing and pharmacy boards are warning health care providers that they cannot prescribe, provide or ...

Roughly 1 in 8 Americans lives with IBS, and many mistake it for a picky gut.

Moderna and Merck have been running a large Phase III trial in over a thousand high-risk patients who had already had surgery ...

Thanks to a couple, a parcel of Washington Island wetland property will be protected for future generations. Door County Land ...

Democrats face uphill fight in Florida ▪ Cassidy shares doubts on FDA nominee ▪ Trump downplays bond market concerns ▪ ...

Psilocybin may not simply cause brain chaos. Scientists discovered hidden order that changes with a person's experience and ...

In "Communicating with Payers: Practical Guidance for Sparsentan Access in FSGS," the panel closes the series with practical ...

In "Monitoring Disease Progression and Liver Cancer Risk in Hepatitis B," our experts turn to how chronic hepatitis B ...